Atlas Trials

Monoclonal Antibody Therapy in Treating Patients With Leukemia

Clinical trial NCT00019227 · COMPLETED

Trial details

NCT number
NCT00019227
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
LymphomaRadiation Toxicity
Start date
1996-10-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.